Emergent Biosolutions
EBS
EBS
126 hedge funds and large institutions have $451M invested in Emergent Biosolutions in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 62 increasing their positions, 29 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 113 → 126 (+13)
1.92% more ownership
Funds ownership: 64.42% → 66.34% (+1.9%)
Holders
126
Holding in Top 10
2
Calls
$36K
Puts
–
Top Buyers
| 1 | +$5.77M | |
| 2 | +$3.68M | |
| 3 | +$3.43M | |
| 4 |
Goldman Sachs
New York
|
+$2.13M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$1.72M |
Top Sellers
| 1 | -$4.13M | |
| 2 | -$2.36M | |
| 3 | -$2.25M | |
| 4 |
Bank of New York Mellon
New York
|
-$1.79M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.57M |